17/06/2026
"Breakthrough Cancer Research invests in translational research to improve survival for people with cancer. We are passionate about getting new treatments to the people who need them, and as quickly as possible."
These words from our CEO, Orla Dolan, capture exactly why we were delighted to attend the launch of the new Rinn Advanced Therapies Centre last week.
While immune cell therapies such as CAR-T have transformed outcomes for some people with cancer, access to these innovative treatments remains a challenge. Rinn Advanced Therapies has been established to help change that by building Ireland's capacity to develop, manufacture and deliver personalised immune cell therapies here at home.
As a proud funding partner, Breakthrough Cancer Research is delighted to support this ambitious national initiative by Research Ireland, which brings together more than 60 leading researchers, clinicians, industry partners and people with lived experience to help make these next-generation treatments more effective, accessible and affordable.
The centre places people at the heart of research and will help create the expertise, infrastructure and innovation needed to bring promising laboratory discoveries closer to clinical reality. It will also provide a platform for future Irish-led research in advanced cell therapies for generations to come.
A sincere thank you to Minister James Lawless TD, Research Ireland, the Rinn Advanced Therapies leadership team, our Public and Patient Involvement and Engagement Panel, and all partners involved in bringing this important initiative to life.
Together, we are helping to create a future where more people can access new, better, kinder, smarter and more effective treatments for people with cancer.
